{"id":62242,"date":"2025-11-21T13:06:38","date_gmt":"2025-11-21T12:06:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/"},"modified":"2025-11-21T13:06:38","modified_gmt":"2025-11-21T12:06:38","slug":"bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/","title":{"rendered":"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth"},"content":{"rendered":"<div>\n<p>MINNEAPOLIS&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/CEOAnnouncement?src=hash\" target=\"_blank\">#CEOAnnouncement<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbebright.com%2F&amp;esheet=54361737&amp;newsitemid=20251121617487&amp;lan=en-US&amp;anchor=beBright&amp;index=1&amp;md5=5a30591ef770473ea95aeb018fbe605d\" rel=\"nofollow\" shape=\"rect\">beBright<\/a>, a doctor-founded, doctor-led dual-specialty support organization focused on integrated pediatric and orthodontic care, today announced the appointment of Kyle Clay as Chief Executive Officer. Kyle, who most recently served as Chief Operating Officer, will lead beBright\u2019s next phase of organic growth and continue advancing the company\u2019s mission to deliver exceptional experiences and life-changing outcomes for children and families.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/5\/Kyle_Clay1173.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/22\/Kyle_Clay1173.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/5\/Kyle_Clay1173.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/21\/Kyle_Clay1173.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2650980\/5\/beBright-Logo-wTag-Spot-Color.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2650980\/22\/beBright-Logo-wTag-Spot-Color.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2650980\/5\/beBright-Logo-wTag-Spot-Color.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2650980\/21\/beBright-Logo-wTag-Spot-Color.jpg\"><\/a><\/p>\n<p>\nSince joining beBright, Kyle has driven operational transformation, expanded support systems for providers, and built scalable infrastructure to support a rapidly growing network. He brings extensive multi-site healthcare experience, including prior C-suite roles in dental services and operational leadership roles at DaVita. He also has a strong academic and service background, holding a B.S. in Economics from the United States Military Academy at West Point and an MBA from the Owen Graduate School of Management at Vanderbilt University.<\/p>\n<p>\n\u201cbeBright was founded on the belief that integrated pediatric and orthodontic care is a unique and superior care delivery model in dentistry,\u201d said Kyle, Chief Executive Officer of beBright. \u201cOur role is to empower our doctors and teams with the best workflows and culture in the industry so children feel cared for, families feel supported, and our practices can achieve their highest potential. I am honored to lead this next chapter as we elevate the beBright POP model, invest in our communities, and build a platform where partnership, innovation and execution thrive together.\u201d<\/p>\n<p>\nBrad Coppens, Senior Partner at InTandem Capital Partners and Member of the Board of Directors of beBright, added: \u201cFrom day one, Kyle has demonstrated the blend of operational rigor, cultural stewardship and forward-thinking strategy that defines great healthcare leadership. He is exactly the leader who can take beBright to the next level.\u201d<\/p>\n<p>\nUnder Kyle\u2019s direction, beBright will continue to invest in:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nA people-first culture that supports exceptional teams and empowers practice administrators and doctors to lead<\/li>\n<li>\nScaling the beBright POP integrated pediatric and orthodontic care model across current and new markets<\/li>\n<li>\nTechnology, analytics and operational support that help practices grow while preserving clinical autonomy<\/li>\n<\/ul>\n<p>\nThe beBright leadership team will remain focused on strengthening patient experience, elevating clinical standards and supporting sustainable, data-driven organic growth across the platform.<\/p>\n<p>\n<b>About beBright<\/b><\/p>\n<p>\nbeBright is a doctor-founded, doctor-led dual-specialty support organization built on a culture of passion, innovation and uncompromising standards. Through its integrated pediatric dentistry and orthodontics model, the beBright POP, beBright partners with exceptional providers to deliver unparalleled pediatric and orthodontic experiences that transform patient journeys through innovative integration, meticulous quality and compassionate service.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact<\/b><br \/>Jordan Meyer<br \/>\n<br \/>Vice President, Marketing<br \/>\n<br \/>beBright<br \/>\n<br \/>612.670.3414<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:marke&#116;&#105;&#110;&#103;&#64;&#98;&#101;&#98;&#114;&#105;&#103;&#104;&#116;&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#109;&#x61;&#x72;k&#101;&#x74;i&#110;&#x67;&#x40;&#98;&#x65;&#x62;r&#105;&#x67;h&#116;&#x2e;&#x63;&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MINNEAPOLIS&#8211;(BUSINESS WIRE)&#8211;#CEOAnnouncement&#8212;beBright, a doctor-founded, doctor-led dual-specialty support organization focused on integrated pediatric and orthodontic care, today announced the appointment of Kyle Clay as Chief Executive Officer. Kyle, who most recently served as Chief Operating Officer, will lead beBright\u2019s next phase of organic growth and continue advancing the company\u2019s mission to deliver exceptional experiences and life-changing &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62242","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS&#8211;(BUSINESS WIRE)&#8211;#CEOAnnouncement&#8212;beBright, a doctor-founded, doctor-led dual-specialty support organization focused on integrated pediatric and orthodontic care, today announced the appointment of Kyle Clay as Chief Executive Officer. Kyle, who most recently served as Chief Operating Officer, will lead beBright\u2019s next phase of organic growth and continue advancing the company\u2019s mission to deliver exceptional experiences and life-changing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-21T12:06:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/22\/Kyle_Clay1173.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth\",\"datePublished\":\"2025-11-21T12:06:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/\"},\"wordCount\":447,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251121617487\\\/en\\\/2651294\\\/22\\\/Kyle_Clay1173.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/\",\"name\":\"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251121617487\\\/en\\\/2651294\\\/22\\\/Kyle_Clay1173.jpg\",\"datePublished\":\"2025-11-21T12:06:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251121617487\\\/en\\\/2651294\\\/22\\\/Kyle_Clay1173.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251121617487\\\/en\\\/2651294\\\/22\\\/Kyle_Clay1173.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/","og_locale":"en_US","og_type":"article","og_title":"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth - Pharma Trend","og_description":"MINNEAPOLIS&#8211;(BUSINESS WIRE)&#8211;#CEOAnnouncement&#8212;beBright, a doctor-founded, doctor-led dual-specialty support organization focused on integrated pediatric and orthodontic care, today announced the appointment of Kyle Clay as Chief Executive Officer. Kyle, who most recently served as Chief Operating Officer, will lead beBright\u2019s next phase of organic growth and continue advancing the company\u2019s mission to deliver exceptional experiences and life-changing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-21T12:06:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/22\/Kyle_Clay1173.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth","datePublished":"2025-11-21T12:06:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/"},"wordCount":447,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/22\/Kyle_Clay1173.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/","url":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/","name":"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/22\/Kyle_Clay1173.jpg","datePublished":"2025-11-21T12:06:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/22\/Kyle_Clay1173.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251121617487\/en\/2651294\/22\/Kyle_Clay1173.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bebright-appoints-kyle-clay-as-chief-executive-officer-to-lead-next-phase-of-integrated-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62242"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62242\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}